Law Seminars International Presents:

The 28th Annual Seattle Technology & IP Conference focusing on

Life Sciences

New legal developments, regulations, enforcement, litigation, challenges and opportunities for one of the area's major high-profile industries

In collaboration with Life Science Washington

December 5 & 6, 2019

Seattle, WA

Download PDF Brochure
Seminar Image

Program Overview

Who Should Attend

In-house and outside counsel, industry executives, scientists, agency officials and consultants involved with developing, using and protecting intellectual property for life science companies or with consumer protection issues arising from the use of new technologies in the operations and marketing of life science companies.

Why You Should Attend

This annual conference will bring you up to date on IP and technology developments, with a particular focus on the business of life science as Seattle's major high profile tech industry today. Big data, machine learning and new applications for artificial intelligence are the foundation for digital health with its reliance on cybersecurity, patent privacy and data protection. Thus just as these concepts have revolutionized business, academic research and the practice of law in the high tech sector their impact is equally significant in disrupting life sciences and health care itself.

This course will explore the extent to which AI, privacy and cybersecurity affect the healthcare sector including life science research. The identification of new monoclonal antibodies and their uses rely significantly on massive sequence information. Further, there will be new consumer protection issues involving privacy concerns and the potential for data collection practices to trigger antitrust enforcement actions.

Our speakers are experts in their fields and are also engaging presenters. As an industry networking platform, this unique Seattle conference provides meaningful and valuable insights that will help you stay on top of the cutting-edge issues for your industry whether life sciences or high tech.

We hope you will be able to join use for both the program and the reception at the end of the first day. Register now to reserve your seat.

~ Teresa Stanek Rea, Esq. of Crowell & Moring and Katherine C. Spelman, Esq. of Microsoft, Program Co-Chairs

What You Will Learn

  • Determining what constitutes patentable subject matter
  • Claim validity: case study of immunotherapy
  • Cybersecurity, patient privacy and data protection issues for digital health
  • Data, open data and the re-use challenges in R&D
  • Open Source software licensing and hybrid communities
  • Trade secrets as an alternative to patents
  • Damages recovery
  • Digital advertising's surprising backlash
  • Addressing human factors
  • Consumer protection issues and regulatory enforcement
  • Lessons from the opioid litigation regarding potential liability and damages

What Attendees Have Said About Similar Programs

  • "The handouts I've read were very helpful. Thanks for a great seminar!"
  • "Interesting and varied topics - a taste of how complex the space is."
  • "Great and informative with truly impressive speakers."
  • "All speakers were outstanding. A big congratulations to LSI on coordinating such a great faculty and curriculum."

Agenda Day 1

8:30 am

Registration Opens

9:00 am

Introduction & Overview

Teresa Stanek Rea, Esq. , Program Co-Chair
Crowell & Moring / Washington, DC

Katherine C. Spelman, Esq. , Program Co-Chair, Senior Copyright Counsel
Microsoft / Redmond, WA

9:15 am

Determining What Constitutes Patentable Subject Matter

Tips for navigating the case law and determining whether to file: Is a statutory fix needed? What is being proposed and what are the prospects?

Robert L. Stoll, Esq.
Drinker Biddle & Reath / Washington, DC

10:00 am

Break

10:15 am

Claim Validity: Case Study of Immunotherapy and How Best to Claim an Antibody or a Group of Antibodies

Therapeutics using patient's own immune system to fight disease: The challenge of dealing with a technology where advances make the ability to characterize the antibody in even more detail

R. Douglas Bradley, Esq. , Lead Counsel - Global Good & Research
Intellectual Ventures / Bellevue, WA

How the statutory requirement for written description could limit the scope of the claims to a very narrow class of antibodies: The challenge for drafting claims and lessons from recent litigation for attacking or defending them

Patrick Morris, Ph.D., Esq.
Perkins Coie / San Francisco, CA

12:00 pm

Lunch (on your own)

1:15 pm

Data, Open Data and Re-Use Challenges in R&D: The Need for Volumes and Vats, Pools and Lakes, of Data for Effective Machine Learning

Challenges when looking across industries and nations: Recent European Copyright Reform that includes provisions in Article 3 and 4 focusing on sources of data; global initiatives affecting life sciences and artificial intelligence R&D

Brian M. Bot , Principal Scientist
Sage Bionetworks / Seattle, WA

Maja D. Larson, Esq. , General Counsel
Allen Institute / Seattle, WA

Transactional tips for technology companies and healthcare providers in the growing field of digital health

Davina L. Inslee, Esq.
Davis Wright Tremaine / Seattle, WA

3:00 pm

Break

3:15 pm

Intellectual Property Protection

Open Source software licensing and hybrid communities: How changes in the US have led to conflicts with international law and overseas enforcement activity; licensing strategies to enable worldwide compliance

Nicolas Schifano, Esq. , Senior Director and Assistant General Counsel
Microsoft / Redmond, WA

To patent or not to patent: The emergence of trade secrets now appears to offer an alternative to complete disclosure in a patent application: however, they introduce friction into the business and require active protection measures

Mark A. Klapow, Esq.
Crowell & Moring / Washington, DC

Damages recovery: An update on how recent decisions affect the value of IP rights and the enforceability of licensing agreements

Neil Zoltowski , Partner
StoneTurn Group / San Francisco, CA

5:00 pm

Continue the Exchange of Ideas: Reception for Faculty and Attendees

Sponsored by Crowell & Moring

Friday, December 06, 2019

9:00 am

Addressing the Human Factors Involved with Achieving the Promise of Digital Health

Overview of the legal and practical issues: Cybersecurity, patient privacy and data protection

Jodi Daniel, Esq.
Crowell & Moring / Washington, DC

9:45 am

Advertising: Digital Advertising's Surprising Backlash

Sleeping Giants, Bots, and Trolls: Legislative and executive efforts to rein in Section 230 of the CDA and the big platforms, to regulate online speech, and to address digital ad fraud

Christopher A. Cole, Esq.
Crowell & Moring / Washington, DC

The Rise of the Influencer: Advertising in the Age of Kourtney, Khlo, Kendall, Kylie, Kris and (of course) Kanye

Brian G. Murphy, Esq.
Frankfurt Kurnit Klein & Selz / New York, NY

10:45 am

Break

11:00 am

Consumer Protection Issues and Regulatory Enforcement

Primary concerns and enforcement priorities for federal and state regulators

Lesley A. Fair, Esq. , Senior Attorney, Bureau of Consumer Protection
Federal Trade Commission / Washington, DC

Andrea Alegrett, Esq. , Assistant Attorney General
Washington State Attorney General's Office / Seattle, WA

Lessons from the opioid litigation regarding potential liability and damages for misleading marketing and advertising

Gretchen Freeman Cappio, Esq.
Keller Rohrback / Seattle, WA

12:30 pm

Evaluations and Adjourn

Faculty Bios

Teresa Stanek Rea, Teresa Stanek Rea, Program Co-Chair, is a partner and Vice-chair of the Intellectual Property Group at Crowell & Moring. She is the former acting and Deputy Director of the United States Patent and Trademark Office (USPTO), as well as Acting and Deputy Under Secretary of Commerce for Intellectual Property.

Katherine C. Spelman, Katherine C. Spelman, Program Co-Chair, is Senior Copyright Counsel at Microsoft. When she was in private practice, she focused on the development, production, sale and defense of work related to emerging content distribution strategies and challenges.

Andrea Alegrett Andrea Alegrett is an Assistant Attorney General for the Consumer Protection Division of the Washington State Attorney General's Office.She leads the Office's High Tech Unit, which identifies targets of potential violations of state and federal laws.

Brian M. Bot Brian M. Bot is a Principal Scientist and Head of Outreach and Strategic Development at Sage Bionetworks. He has extensive experience working with clinical and genomic data.

R. Douglas Bradley R. Douglas Bradley is Lead Counsel - Global Good & Research at Intellectual Ventures. He previously served as General Counsel for the Infectious Disease Research Institute.

Gretchen Freeman Cappio Gretchen Freeman Cappio is a partner at Keller Rohrback where she has a track record of success in class action and multidistrict litigation.

Christopher A. Cole Christopher A. Cole is Co-chair of the Advertising & Media Group at Crowell & Moring. He focuses on false advertising, unfair competition, reputation, brand disparagement, and intellectual property.

Jodi Daniel Jodi Daniel is a partner at Crowell & Moring and leads the firm's Digital Health Practice. She previously served as the founding director of the Office of Policy in the Office of the National Coordinator for Health Information Technology (ONC), U.S. Department of Health and Human Services (HHS).

Lesley A. Fair Lesley A. Fair is a Senior Attorney with the Federal Trade Commission's Bureau of Consumer Protection, where she has represented the FTC in numerous investigations of deceptive advertising and consumer fraud.

Davina L. Inslee Davina L. Inslee is Of Counsel to Davis Wright Tremaine. A former in-house attorney, she focuses on supporting research and development for diagnostics, machine learning, clean energy, and other transformative technologies, with an emphasis in biotechnology.

Mark A. Klapow Mark A. Klapow is Co-chair of the Litigation Group at Crowell & Moring. He serves as Chair of the Trade Secret Law Committee of AIPLA and and on the Trade Secrets Steering Committee of the Sedona Conference.

Maja D. Larson Maja D. Larson is General Counsel at the Allen Institute. She currently oversees the legal and enterprise risk management functions and previously managed regulatory compliance, grants management, and human resources.

Patrick Morris, Ph.D., Esq. is a partner at Perkins Coie. He focuses on life science and biotechnology patent matters, with a particular emphasis on biologic and small molecule therapeutics. In addition to pharmaceuticals, he has worked with a range of biotechnologies, including genome editing methods such as CRISPR/Cas gene editing, next-generation sequencing methods, genetically engineered microorganisms, and genetic diagnostic methods.

Brian G. Murphy Brian G. Murphy is a partner at Frankfurt Kurnit Klein & Selz. He counsels advertising agencies, advertisers, and entertainment companies as they develop and produce advertising and entertainment properties across all media.

Nicolas Schifano Nicolas Schifano is Senior Director and Assistant General Counsel for Cloud IP at Microsoft. His EU experience includes four years in Belgium as the Director of Standards and Interoperability Policy for Microsoft.

Robert L. Stoll Robert L. Stoll co-chairs the Intellectual Property Group at Drinker Biddle & Reath. He retired from the USPTO as Commissioner for Patents at the end of 2011 after a distinguished 34-year government career.

Neil Zoltowski Neil Zoltowski is a partner at StoneTurn Group. He serves as a consulting and testifying financial expert in complex business disputes, intellectual property litigation, and business and intellectual property valuation matters.

Continuing Education Credits

Live credits: This program qualifies for 9.25 WA MCLE credits. Upon request, we will help you apply for CLE credits in other states and other types of credits.

Location

404 Photo Not Found

The Westin Seattle Hotel

1900 Fifth Avenue in Seattle, WA 98101
(206) 728-1000

The conference will be held at the The Westin Seattle Hotel at 1900 Fifth Avenue in Seattle, WA 98101.
More about the Location
Map & Directions

Register or Purchase a Replay